Completely agree, so why not the announcement that its in the pipeline for filing IND?
To me this points more to them shelving AXAL for the time being, just like Ken alluded to on the call. Or fire sale it and bring in HOT cervical at a later date when they're capable (see value) of doing so.
Exactly. Not including HOT cervical in a PR of initial indications doesn’t mean they cannot simply license out that indication, in a package with AXAL cervical. The BP will have both generations covered.